Urolithin a for people with alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This study tests a dietary supplement called Urolithin A (Mitopure®) to see if it helps people with mild-to-moderate Alzheimer's disease. You would take the supplement or a placebo, and researchers will track your memory and daily function over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 55 and 85 years old.
- You must have been diagnosed with Alzheimer's disease and had a test showing amyloid buildup in the brain.
- You must have mild to moderate memory problems (score of 24 or higher on a standard memory test).
- If you take Alzheimer's medication, the dose must have been the same for at least 8 weeks before starting the study.
- You must be able to see and hear well enough to complete tests, and speak Czech fluently.
- You must have a family member or friend who can support you during the study.
- You cannot have other major brain conditions (like Parkinson's or stroke damage), recent serious depression, or unstable diabetes.
- You cannot take certain supplements (NMN or NR) during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing an experimental medicine called QLH2405 in two groups: healthy volunteers (to check safety) and people with mild memory problems due to Alzheimer's. If you qualify, the study may help find out if this new treatment is safe and could slow down memory decline.
This trial tests an experimental medicine called MK-2214 for people with early Alzheimer's (mild cognitive impairment or mild dementia). The goal is to see if it can slow memory and thinking problems.
This trial tests whether a supplement called Neuroaid II can help people with mild to moderate Alzheimer's disease. It is a pill taken alongside your usual Alzheimer's treatments, and the study aims to see if it can slow down memory decline.
This trial tests a new drug called CM383 in people with mild cognitive impairment or mild Alzheimer's disease. The goal is to see if it can help slow down memory loss.
This study tests whether a daily pill (tadalafil, a type of medicine usually used for blood pressure or erectile dysfunction) can help people with early Alzheimer's or mild memory problems. It aims to see if this drug can improve memory and slow down the disease, with the help of regular checkups and brain scans.
This trial tests a drug called masitinib to see if it can help people with mild Alzheimer's disease. You'd get either the drug or a placebo, and doctors will check if your daily living skills and memory slow their decline.
Hear when a new Early Alzheimer's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.